The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy
Abstract
Evidence implicates hyperglycemia-derived oxygen free radicals as mediators of diabetic complications. However, intervention studies with classic antioxidants, such as vitamin E, failed to demonstrate any beneficial effect. Recent studies demonstrate that a single hyperglycemia-induced process of overproduction of superoxide by the mitochondrial electron-transport chain seems to be the first and key event in the activation of all other pathways involved in the pathogenesis of diabetic complications. These include increased polyol pathway flux, increased advanced glycosylation end product formation, activation of protein kinase C, and increased hexosamine pathway flux. Superoxide overproduction is accompanied by increased nitric oxide generation, due to an endothelial NOS and inducible NOS uncoupled state, a phenomenon favoring the formation of the strong oxidant peroxynitrite, which in turn damages DNA. DNA damage is an obligatory stimulus for the activation of the nuclear enzyme poly(ADP-ribose) polymerase. Poly(ADP-ribose) polymerase activation in turn depletes the intracellular concentration of its substrate NAD+, slowing the rate of glycolysis, electron transport, and ATP formation, and produces an ADP-ribosylation of the GAPDH. These processes result in acute endothelial dysfunction in diabetic blood vessels that, convincingly, also contributes to the development of diabetic complications. These new findings may explain why classic antioxidants, such as vitamin E, which work by scavenging already-formed toxic oxidation products, have failed to show beneficial effects on diabetic complications and may suggest new and attractive “causal” antioxidant therapy. New low–molecular mass compounds that act as SOD or catalase mimetics or l-propionyl-carnitine and lipoic acid, which work as intracellular superoxide scavengers, improving mitochondrial function and reducing DNA damage, may be good candidates for such a strategy, and preliminary studies support this hypothesis. This “causal” therapy would also be associated with other promising tools such as LY 333531, PJ34, and FP15, which block the protein kinase β isoform, poly(ADP-ribose) polymerase, and peroxynitrite, respectively. While waiting for these focused tools, we may have other options: thiazolinediones, statins, ACE inhibitors, and angiotensin 1 inhibitors can reduce intracellular oxidative stress generation, and it has been suggested that many of their beneficial effects, even in diabetic patients, are due to this property.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanisms underlying the biological effects of statins and AT-1 receptor blockers differ, even in terms of intracellular antioxidant activity.”
In the citing paper
“Statins and AT-1 receptor blockers protect endothelial function and reduce inflammation in diabetic and nondiabetic subjects, and these effects are convincingly mediated through their intracellular antioxidant activity.”
In the citing paper
“Although this review is concerned with mitochondrial ROS, it should be recognized that considerable ROS derives from outside this organelle, including oxygen radicals from peroxisomal β-oxidation of fatty acids (24), NAD(P)H oxidase (53), xanthine oxidase, arachidonic acid metabolism, microsomal P-450 enzymes (75), and the prooxidant heme molecule (226).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [53]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Nitric oxide: physiology, pathophysiology, and pharmacology.
Moncada, S., Palmer, R. M., & Higgs, E. A. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06663-3 · Cited by 15,525
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Cited by
Sorted by citations
Items 301–400 of 732
Fareed, M., Salam, N., Khoja, A. T., Mahmoud, M. A., & Ahamed, M. M. U. (2017) · International Journal of Medical Research & Health Sciences · Cited by 32
Foster, S. R., Dilworth, L., Thompson, R. K., Alexander-Lindo, R. L., & Omoruyi, F. O. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.07.024 · Cited by 33
In Vitro and In Vivo Antioxidant and Anti-Hyperglycemic Activities of Moroccan Oat Cultivars
Marmouzi, I., Karym, E. M., Saïdi, N., Meddah, B., Kharbach, M., Masrar, A., Bouabdellah, M., Chabraoui, L., Allali, K. E., Cherrah, Y., et al. (2017) · Antioxidants · doi:10.3390/antiox6040102 · Cited by 34
Skin Autofluorescence Increases Postprandially in Human Subjects
Stirban, A. O., Nandrean, S., Negrean, M., Koschinsky, T., & Tschoepe, D. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2007.0275 · Cited by 33
Irshaid, F. I., Mansi, K., & Aburjai, T. A. (2010) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2010.423.430 · Cited by 33
Melatonin as Antioxidant Under Pathological Processes
Tomás‐Zapico, C., & Coto‐Montes, A. M. (2007) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/187221407779814561 · Cited by 33
Treatment of Metabolic Syndrome Slows Progression of Diabetic Nephropathy
Pérez, E. G. D., Almeda‐Valdés, P., Ramos, D. C., Campos-Barrera, E., Muñóz-Hernández, L. L., & Gomez-Perez, F. J. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0056 · Cited by 32
Alsenosy, A. A., El‐Far, A. H., Sadek, K. M., Ibrahim, S. A., Shukry, M., Sayed-Ahmed, A., Jaouni, S. K. A., & Mousa, S. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222410 · Cited by 36
Effects of diet and antihyperglycemic drugs on erectile dysfunction: A systematic review
Defeudis, G., Mazzilli, R., Tommaso, A. M. D., Zamponi, V., Carlomagno, F., Tuccinardi, D., Watanabe, M., Faggiano, A., & Gianfrilli, D. (2022) · Andrology · doi:10.1111/andr.13192 · Cited by 32
Chiarelli, F., Santilli, F., Sabatino, G., Blasetti, A., Tumini, S., Cipollone, F., Mezzetti, A., & Verrotti, A. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000141990.12375.13 · Cited by 32
Novelli, M., Bonamassa, B., Masini, M., Funel, N., Canistro, D., Tata, V. D., Martano, M., Soleti, A., Campani, D., Paolini, M., et al. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0524-7 · Cited by 31
Onaran, İ., Güven, G. S., Özdaş, Ş., Kanıgür, G., & Vehid, S. (2006) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.06.036 · Cited by 32
Anand, A., Komati, A., Katragunta, K., Shaik, H., Nagendla, N. K., Kuncha, M., Mudiam, M. K. R., Babu, K. S., & Tiwari, A. K. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.128313 · Cited by 31
Abu-Serie, M. M., El-Gamal, B., Elkersh, M. A., & ElSaadani, M. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0124-0 · Cited by 31
Youn, J.-Y., Zhou, J. F., & Cai, H. “. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1313 · Cited by 31
Faheem, N. M., & Askary, A. E. (2017) · PubMed Central · doi:10.22038/ijbms.2017.8839 · Cited by 31
MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death
Jiao, D., Zhang, H., Jiang, Z., Huang, W., Liu, Z., Wang, Z., Wang, Y., & Wu, H. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1667-0 · Cited by 32
CR-6 protects glutathione peroxidase activity in experimental diabetes
Miranda, M., Muriach, M., Almansa, I., Arnal, E., Messeguer, Á., Díaz-Llopis, M., Romero, F. J., & Bosch‐Morell, F. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.08.001 · Cited by 31
High glucose concentrations per se do not adversely affect human sperm function in vitro
Portela, J. M. D., Tavares, R. S., Mota, P. C., Ramalho‐Santos, J., & Amaral, S. (2015) · Reproduction · doi:10.1530/rep-15-0100 · Cited by 31
Genetic susceptibility of diabetic retinopathy
Patel, S., Chen, H., Tinkham, N. H., & Zhang, K. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0046-6 · Cited by 31
Agatonović-Kuštrin, S., & Morton, D. W. (2018) · MethodsX · doi:10.1016/j.mex.2018.07.013 · Cited by 34
Sulfaphenazole treatment restores endothelium-dependent vasodilation in diabetic mice
Elmi, S., Sallam, N. A., Rahman, M. M., Teng, X., Hunter, A. L., Moien‐Afshari, F., Khazaei, M., Granville, D. J., & Laher, I. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.09.001 · Cited by 31
Gumbar, S., Bhardwaj, S., Mehan, S., Khan, Z., Narula, A. S., Kalfin, R. E., Tabrez, S. S. M., Zughaibi, T. A., & Wasi, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1218506 · Cited by 30
Dongway, A. C., Faggad, A., Zaki, H., & Abdalla, B. (2015) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s85451 · Cited by 34
Khong, F. L., Zhang, Y., Edgley, A. J., Qi, W., Connelly, K. A., Woodman, O. L., Krum, H., & Kelly, D. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022777 · Cited by 30
Sochett, E. B., Noone, D. G., Grattan, M., Slorach, C., Moineddin, R., Elia, Y. T., Mahmud, F. H., Dunger, D. B., Dalton, N. R., Cherney, D. Z. I., et al. (2017) · Cytokine · doi:10.1016/j.cyto.2017.07.013 · Cited by 30
Negi, C. K., & Jena, G. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.026 · Cited by 30
Çevik, Ö. D., Çadırcı, S., Şener, T. E., Tınay, İ., Akbal, C., Tavukçu, H. H., Çetınel, Ş., Kıran, D., & Şener, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.814912 · Cited by 30
Antidiabetic potential of Zanthoxylum armatum bark extract on streptozotocin-induced diabetic rats
Karki, H., Upadhayay, K., Pal, H., & Singh, R. (2014) · International Journal of Green Pharmacy · doi:10.4103/0973-8258.129568 · Cited by 30
Su, Y., Xu, Y., Sun, Y., Li, J., Liu, X.-M., Li, Y., Liu, G., & Bi, S. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181bfb1df · Cited by 30
Wang, L., Tian, W., Zaid, U. B., Li, G., Li, H., Guan, R., Gao, Z., & Xin, Z. (2014) · The Journal of Sexual Medicine · doi:10.1111/jsm.12533 · Cited by 30
Xu, P., Xiao, J., & Chi, S. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22763 · Cited by 29
Bostancıeri, N., Elbe, H., Eşrefoğlu, M., & Vardı, N. (2021) · Biotechnic & Histochemistry · doi:10.1080/10520295.2021.1918766 · Cited by 29
The therapeutic prospects of using l-carnitine to manage hypertension-related organ damage
Mate, A., Miguel‐Carrasco, J. L., & Vázquez, C. M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.014 · Cited by 29
Pradeep, A., Agarwal, E., Bajaj, P. S., & Rao, N. S. (2013) · Contemporary Clinical Dentistry · doi:10.4103/0976-237x.118342 · Cited by 29
Yönem, A., Duran, C., Ünal, M., İpçioğlu, O. M., & Özcan, Ö. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.03.001 · Cited by 29
Ceriello, A., Esposito, K., Ihnat, M. A., Thorpe, J. E., & Giugliano, D. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02928.x · Cited by 30
Self-citationSemaming, Y., Kukongviriyapan, U., Kongyingyoes, B., Thukham-mee, W., & Pannangpetch, P. (2015) · Phytotherapy Research · doi:10.1002/ptr.5520 · Cited by 29
Eichner, N. Z. M., Gaitán, J. M., Gilbertson, N. M., Khurshid, M., WELTMAN, A. L., & Malin, S. K. (2018) · Experimental Physiology · doi:10.1113/ep087305 · Cited by 29
Inhibition of acetylcholine-induced EDHF response by elevated glucose in rat mesenteric artery
Özkan, M. H., & Uma, S. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.02.036 · Cited by 29
Aloesin as a medical food ingredient for systemic oxidative stress of diabetes
Yimam, M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i9.1097 · Cited by 28
Gentile, V., Antonini, G., Bertozzi, M. A., Dinelli, N., Rizzo, C., Virmani, A., & Koverech, A. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903138416 · Cited by 28
The effect of insulin-loaded trimethylchitosan nanoparticles on rats with diabetes type I
Jamshidi, M., Ziamajidi, N., Khodadadi, I., Dehghan, A., Kalantarian, G., & Abbasalipourkabir, R. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.097 · Cited by 28
Abdelhady, M. I. S., Kamal, A. M., Othman, S. M., Mubarak, M. S., & Hadda, T. B. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1101-2 · Cited by 28
Siboto, A., Sibiya, N. H., Khathi, A., & Ngubane, P. S. (2018) · Journal of Diabetes Research · doi:10.1155/2018/7341242 · Cited by 27
Diabetes and Sperm DNA Damage: Efficacy of Antioxidants
Laleethambika, N., Venugopal, A., Manojkumar, C., Muruganandam, I., Giridharan, B., Ravimanickam, T., & Vellingiri, B. (2018) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-018-0012-9 · Cited by 28
Resveratrol and Cardiac Fibrosis Prevention and Treatment
Zivarpour, P., Reiner, Ž., Hallajzadeh, J., & Mirsafaei, L. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210212125003 · Cited by 27
Yao, R., Cao, Y., Wang, C., Xu, L. L., Zhang, X., Deng, Y., Li, F., & Wang, S. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03218-0 · Cited by 27
Dworacka, M., Winiarska, H., Borowska, M., Abramczyk, M., Bobkiewicz-Kozłowska, T., & Dworacki, G. (2007) · Circulation Journal · doi:10.1253/circj.71.962 · Cited by 27
Alanazi, A. Z., Alqinyah, M., Alhamed, A. S., Mohammed, H., Raish, M., Aljerian, K., Alsabhan, J. F., & Alhazzani, K. (2024) · Redox Report · doi:10.1080/13510002.2024.2416835 · Cited by 26
Pang, X., Makinde, E. A., Eze, F. N., & Olatunji, O. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.737764 · Cited by 27
Assessment of plasma antioxidant levels in type 2 diabetes patients
Hisalkar, P., Patne, A., & Fawade, M. (2012) · Cited by 26
Empowering patients during insulin initiation: a real-world approach.
LaSalle, J. R. (2010) · PubMed · Cited by 26
Uchiyama, Y., Suzuki, T., Mochizuki, K., & Goda, T. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf401635w · Cited by 26
Beer, S., Moren, X., Ruiz, J. C., & James, R. W. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.09.005 · Cited by 26
Complications of type 1 diabetes: new molecular findings
Stirban, A. O., Rosen, P., & Tschoepe, D. (2008) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20057 · Cited by 26
Mulberry granules protect against diabetic cardiomyopathy through the AMPK/Nrf2 pathway
Liu, Y., Zhao, Y., Wang, S., Zhou, Y., Tang, Z., & Li, F. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3050 · Cited by 26
Sanna, R. S., Subramanyam Muthangi, V., V, Chandrasekhar Sagar, B. K., & Devi, S. A. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0320-5 · Cited by 25
Nicolson, G. L., Ferreira, G., Ash, M. E., Settineri, R. A., & Escribá, P. V. (2021) · Membranes · doi:10.3390/membranes11120944 · Cited by 28
Kim, H. W., Lim, J. H., Kim, M. Y., Chung, S., Shin, S. J., Chung, H. W., Choi, B. S., Kim, Y.-S., Chang, Y. S., & Park, C. W. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq610 · Cited by 26
Ryanodine Receptor: A New Therapeutic Target to Control Diabetic Cardiomyopathy
Turan, B., & Vassort, G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3725 · Cited by 27
Chen, Y., Xu, X., Sheng, M., Zheng, Z. J., & Gu, Q. (2011) · PubMed Central · Cited by 25
Irshaid, F. I., Mansi, K., Bani-Khaled, A., & Aburjia, T. (2012) · Europe PMC (PubMed Central) · Cited by 25
Hyperglycemia and acute kidney injury in critically ill children
Gordillo, R., Ahluwalia, T., & Woroniecki, R. P. (2016) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s115096 · Cited by 25
Short-term effects of diabetes on neurosteroidogenesis in the rat hippocampus
Romano, S., Mitro, N., Diviccaro, S., Spezzano, R., Audano, M., García‐Segura, L. M., Caruso, D., & Melcangi, R. C. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.11.019 · Cited by 25
Differential effects of ETA and ETB receptor antagonism on oxidative stress in type 2 diabetes
Elgebaly, M. M., Portik‐Dobos, V., Sachidanandam, K., Rychly, D. J., Malcom, D. R., Johnson, M. H., & Ergul, A. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.05.006 · Cited by 25
Effect of irbesartan on nitrotyrosine generation in non-hypertensive diabetic patients
Ceriello, A., Assaloni, R., Da Ros, R., Maier, A., Quagliaro, L., Piconi, L., Esposito, K., & Giugliano, D. (2004) · Diabetologia · doi:10.1007/s00125-004-1487-3 · Cited by 24
Self-citationGraft Survival of Diabetic Versus Nondiabetic Donor Tissue After Initial Keratoplasty
Vislisel, J. M., Liaboe, C. A., Wagoner, M. D., Goins, K. M., Sutphin, J. E., Schmidt, G. A., Zimmerman, M. B., & Greiner, M. A. (2015) · Cornea · doi:10.1097/ico.0000000000000378 · Cited by 24
Almohaimeed, H. M., Mohammedsaleh, Z. M., Batawi, A. H., Balgoon, M. J., Ramadan, O., Baz, H. A., Jaouni, S. K. A., & Ayuob, N. N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.727049 · Cited by 24
Neisi, A., Farhadi, M., Cheraghian, B., Dargahi, A., Ahmadi, M., Takdastan, A., & Angali, K. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24517 · Cited by 25
Reducing oxidative stress in patients with type 2 diabetes mellitus: A primary care call to action
Unger, J. (2008) · Insulin · doi:10.1016/s1557-0843(08)80037-1 · Cited by 24
Taguchi, K., Kobayashi, T., Hayashi, Y., Matsumoto, T., & Kamata, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.026 · Cited by 23
Adverse cardiac responses to alpha-lipoic acid in a rat-diabetic model: possible mechanisms?
Al-Rasheed, N. M., Al‐Rasheed, N. M., Attia, H., Hasan, I. H., Alamin, M. A., Al‐Ajmi, H. N., & Mohamad, R. A. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0252-9 · Cited by 24
Kim, H. J., Oh, S. S., Lee, D. W., Kwon, J., & Park, E. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16101870 · Cited by 23
Melatonin ameliorates diabetes-induced brain injury in rats
Amer, M. E., Othamn, A. I., & El-Missiry, M. A. (2021) · Acta Histochemica · doi:10.1016/j.acthis.2020.151677 · Cited by 23
Kasznicki, J. (2014) · Archives of Medical Science · doi:10.5114/aoms.2014.42588 · Cited by 27
Jankyova, S., Kucera, P., Goldenberg, Z., Vavrincová-Yaghi, D., Navarová, J., Kyseľová, Z., Štolc, S., Klimas, J., Racanska, E., & Mátyás, Š. (2009) · Phytotherapy Research · doi:10.1002/ptr.2776 · Cited by 23
Late administration of Mn porphyrin-based SOD mimic enhances diabetic complications
Ali, D. K., Oriowo, M. A., Tovmasyan, A. G., Batinic̈‐Haberle, I., & Benov, L. (2013) · Redox Biology · doi:10.1016/j.redox.2013.09.005 · Cited by 23
Mihailović, M., Јovanović, J. A., Uskoković, A. S., Dinić, S., Grdović, N., Marković, J., Ibrahim, M., Ana, Š. D., Poznanović, G., & Vidaković, M. (2012) · Journal of Functional Foods · doi:10.1016/j.jff.2012.10.016 · Cited by 23
The Genetic Link Between Diabetes and Atherosclerosis
Ross, S. A., Gerstein, H. C., & Paré, G. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.01.016 · Cited by 23
Oak, J., Youn, J.-Y., & Cai, H. “. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-65 · Cited by 23
Taş, S., Çelikler, S., Ziyanok, S., Sarandöl, E., & Dirican, M. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1729 · Cited by 23
Shiba, C., Shiba, T., Takahashi, M., Matsumoto, T., & Hori, Y. (2016) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-016-3437-4 · Cited by 23
Novelli, M., D’Aleo, V., Lupi, R., Paolini, M., Soleti, A., Marchetti, P., & Masiello, P. (2007) · Pancreas · doi:10.1097/mpa.0b013e318150e4f2 · Cited by 24
Akhtar, A., Amir, A., Hussain, W., Ghaffar, A., & Rasool, N. (2019) · Current Computer - Aided Drug Design · doi:10.2174/1573409915666190130164923 · Cited by 22
Kawakami, T., Urakami, S., Hirata, H., Tanaka, Y., Nakajima, K., Enokida, H., Shiina, H., Ogishima, T., Tokizane, T., Kawamoto, K., et al. (2009) · International Journal of Impotence Research · doi:10.1038/ijir.2009.28 · Cited by 22
Insulin initiation and intensification in patients with T2DM for the primary care physician
Unger, J. R. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s14653 · Cited by 22
Mirmiran, P., Hosseinpour‐Niazi, S., & Azizi, F. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.113 · Cited by 22
Chertow, B. S. (2004) · PubMed Central · Cited by 22
Pathogenetic Loop Between Diabetes and Cell Senescence
Testa, R., & Ceriello, A. (2007) · Diabetes Care · doi:10.2337/dc07-1534 · Cited by 22
Self-citationDashtban, M., Sarir, H., & Omidi, . (2016) · Advanced Biomedical Research · doi:10.4103/2277-9175.185575 · Cited by 21
Am, A., Uddin, M. S., Wahid, F., Mohammed, A. I., & Rahman, M. M. (2016) · Journal of Neurology and Neuroscience · doi:10.21767/2171-6625.1000126 · Cited by 21
The Relationship between Pharmacological Properties and Structure- Activity of Chrysin Derivatives
Li, Y., Li, Y., He, J., Liu, D., Zhang, Q., Li, K., Zheng, X., Tang, G., Guo, Y. C., & Liu, Y. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557518666180424094821 · Cited by 21
Wang, M., Xiong, Y., Zhu, W., Ruze, R., Xu, Q., Yan, Z., Zhu, J., Zhong, M., Cheng, Y., Hu, S., et al. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05073-3 · Cited by 24
Kusunoki, Y., Katsuno, T., Nakae, R., Watanabe, K., Akagami, T., Ochi, F., Tokuda, M., Murai, K., Miuchi, M., Miyagawa, J., et al. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.01.040 · Cited by 21
Sultuybek, G. K., Özdaş, Ş., Çurgunlu, A., V. Tezcan, & Onaran, İ. (2007) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.2007.18.2.129 · Cited by 21
Méndez, M. M., Folgado, J., Tormo, C., Artero, A., Ascaso, M., Martínez‐Hervás, S., Chaves, F. J., Ascaso, J. F., & Real, J. T. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.05.023 · Cited by 21
Hajam, Y. A., Rai, S., Pandi-Perumal, S. R., Brown, G. M., Reiter, R. J., & Cardinali, D. P. (2021) · Neuroendocrinology · doi:10.1159/000520280 · Cited by 20
Chen, L., Fei, S., & Olatunji, O. J. (2022) · Molecules · doi:10.3390/molecules27072208 · Cited by 20
Starodubtseva, M. N., Kuznetsova, T. G., Yegorenkov, N. I., & Cherenkevich, S. N. (2008) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-008-0036-3 · Cited by 20
Metadata
- Authors
- Ceriello, A.
- Affiliations
- University of Udine (IT)
- Corresponding author
- Ceriello, Antonio
- ORCID
- Ceriello, Antonio
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2003-05-01
- Volume
- 26
- Issue
- 5
- Pages
- 1589-1596
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2058550328
- Cited by
- 734
- References
- 102
- Citations by year
- 2026: 9 · 2025: 8 · 2024: 16 · 2023: 15 · 2022: 16 · 2021: 24 · 2020: 13 · 2019: 27 · 2018: 34 · 2017: 41 · 2016: 33 · 2015: 34 · 2014: 46 · 2013: 49 · 2012: 50
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, diabetes complications, superoxide, mitochondrial electron transport chain, hyperglycemia, polyol pathway, advanced glycation end products, protein kinase C, hexosamine biosynthetic pathway, nitric oxide, peroxynitrite, DNA damage, poly(ADP-ribose) polymerase, NAD+ depletion, endothelial dysfunction, antioxidant therapy, superoxide dismutase mimetic, catalase mimetics, alpha-lipoic acid, PJ34, thiazolidinediones, statins, ACE inhibitors, angiotensin receptor blockers
- MeSH terms
- Antioxidants, Diabetes Mellitus, DNA Damage, Endothelium, Vascular, Humans, Hyperglycemia, Models, Biological, Oxidative Stress, Peroxynitrous Acid, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review